β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell Destruction

Xiaoxia Liu, Sophie Turban, Roderick N Carter, Shakil Ahmad, Lynne Ramage, Scott P Webster, Brian R Walker, Jonathan R Seckl, Nicholas M Morton

Research output: Contribution to journalArticlepeer-review

Abstract

Progression and severity of type 1 diabetes is dependent upon inflammatory induction of nitric oxide production and consequent pancreatic β-cell damage. Glucocorticoids (GCs) are highly effective anti-inflammatory agents but have been precluded in type 1 diabetes and in islet transplantation protocols because they exacerbated insulin resistance and suppressed β-cell insulin secretion at the high-doses employed clinically. In contrast, physiological-range elevation of GC action within β-cells ameliorated lipotoxic β-cell failure in transgenic mice overexpressing the intracellular enzyme 11β-hydroxysteroid dehydrogenase type 1 (MIP-HSD1(tg/+) mice). Here, we tested the hypothesis that elevated β-cell 11beta-HSD1 protects against the β-cell destruction elicited by streptozotocin (STZ), a toxin that dose-dependently mimics aspects of inflammatory and autoimmune β-cell destruction. MIP-HSD1(tg/+) mice exhibited an episodic protection from the severe hyperglycemia caused by a single high dose of STZ associated with higher and sustained β-cell survival, maintained β-cell replicative potential, higher plasma and islet insulin levels, reduced inflammatory macrophage infiltration and increased anti-inflammatory T regulatory cell content. MIP-HSD1(tg/+) mice also completely resisted mild hyperglycemia and insulitis induced by multiple low-dose STZ administration. In vitro, MIP-HSD1(tg/+) islets exhibited attenuated STZ-induced nitric oxide production, an effect reversed with a specific 11beta-HSD1 inhibitor. GC regeneration selectively within β-cells protects against inflammatory β-cell destruction, suggesting therapeutic targeting of 11beta-HSD1 may ameliorate processes that exacerbate type 1 diabetes and that hinder islet transplantation.

Original languageEnglish
Pages (from-to)165
JournalFrontiers in Endocrinology
Volume5
Early online date14 Oct 2014
DOIs
Publication statusPublished - 14 Oct 2014

Fingerprint

Dive into the research topics of 'β-Cell-Specific Glucocorticoid Reactivation Attenuates Inflammatory β-Cell Destruction'. Together they form a unique fingerprint.

Cite this